Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Baxter
MedTech
Baxter CEO José Almeida to retire, effective immediately
The news comes just days after Baxter completed the sale of its Vantive kidney care unit through a $3.8 billion deal with the Carlyle Group.
Conor Hale
Feb 3, 2025 11:34am
IV fluid shortage could change patient hydration management
Nov 20, 2024 11:47am
What medtech CEOs are saying about Trump's potential tariffs
Nov 8, 2024 11:48am
Baxter sells $4.5B kidney care unit to Carlyle Group for $3.8B
Aug 13, 2024 11:00am
Baxter weighs sale vs. spinout for Vantive kidney care division
Mar 4, 2024 10:46am
Eitan infusion pumps join Baxter, B. Braun in spate of recalls
Dec 4, 2023 10:28am
